|
At Avesthagen, we believe in bringing science to life
Drawing science out of the confines of the
laboratory and setting it free to work in the real,
everyday world.
We aim to enhance the quality and texture
of human lives through predictive preventive
personalized healthcare.
Our scientific and business-related activities,
whether in the field of pioneering research,
innovation, product development or strategic
alliances, stem from our commitment to thread
research with humanity.
Since officially commencing business operations in 2001, we have
grown into one of India’s leading Systems Biology Company, based
on continuous innovation, which we believe is vital for sustainable
development and growth.
Today, Avesthagen has four main strategic business units:
From partnering early discovery in Science Innovation, to a
development Biosimilar therapeutics.
Our activities include development of clinically validated botanical
bioactives, derived from Indian medicinal plants.
We partner for our agri-biotechnologies product pipeline and
spearhead pioneering research projects.
Avesthagen has strategic partnerships at every stage in the value chain
with appropriate partners, both public and private, for development
of novel technologies. The uniqueness of Avesthagen is its ability to
combine deep science with commercial acumen, well supported by the
“India Advantage”.
Avesthagen is proud to enhance India’s emerging image as a
technology powerhouse, deploying indigenous capabilities to meet
global challenges and provide for a better future.
Avesthagen
team is backed by well-trained scientific research team and state of the
art fully equipped research laboratories and a bioinformatics center.
Company's high caliber science and technology leads to meticulous internal
quality control measures and indisputable results.
Through its in-house
research programs and alliances, company has developed strong competencies
in genomics, proteomics, metabolomics and bioinformatics, resulting in an
integrated biotechnology platform, which is applied in its focus areas to
aid the rapid development of novel therapeutics and molecular diagnostic
products.
|
|
